Leydig cell tumor in a patient with 49,XXXXY karyotype: a review of literature

Reproductive Biology and Endocrinology

Igor Tauveron⁴  Françoise Desbiez¹  Fréderic Franck³  Béatrice Roche¹  Marie Batisse-Lignier⁴  Laura Bogenmann¹  Salwan Maqdasy² 

[1] Service d’endocrinologie, diabétologie et maladies métaboliques, CHU Clermont-Ferrand, Clermont-Ferrand, F-63003, France;Service de Médecine Nucléaire, Centre Jean Perrin, 58 rue Montalembert, Clermont-Ferrand, F-63011, France;SIPATH Clermont-Ferrand, Clermont-Ferrand, F-63003, France;UMR CNRS 6293, INSERM U1103, Université Clermont-Auvergne, Génétique Reproduction et Développement, BP 10448, Aubiere, 63177, France

关键词: Endocrine function;    Leydigioma;    Leydig cell tumor;    Fraccaro’s syndrome;    49,XXXXY;    Klinefelter;   

Others  :  1218506
DOI  :  10.1186/s12958-015-0071-7

 received in 2015-05-05, accepted in 2015-06-30,  发布年份 2015

【 摘 要 】

49,XXXXY pentasomy or Fraccaro’s syndrome is the most severe variant of Klinefelter’s syndrome (KS) affecting about 1/85000 male births. The classical presentation is the triad: mental retardation, hypergonadotropic hypogonadism and radio ulnar synostosis. Indeed, the reproductive function of Fraccaro’s syndrome is distinguished from KS. Besides, Leydig cell tumors are described in cases of KS, but never documented in the Klinefelter variants.

We describe a young adult of 22 years old who presented with hyper gonadotropic hypogonadism, delayed puberty and bilateral micro-cryptorchidism. Chromosomal pentasomy was confirmed since infancy. Bilateral orchidectomy revealed a unilateral well-circumscribed Leydig cell tumor associated with bilateral Leydig cell hyperplasia.

Inspired from reporting the first case of Leydig cell tumor in a 49,XXXXY patient, we summarize the particularities of testicular function in 49,XXXXY from one side, and the risk and mechanisms of Leydig cell tumorigenesis in Klinefelter variants on the other side. The histological destructions in 49,XXXXY testes and hypogonadism are more profound than in Klinefelter patients, with early Sertoli, Leydig and germ cell destruction. Furthermore, the risk of Leydigioma development in KS and its variants remains a dilemma. We believe that the risk of Leydigioma is much higher in KS than the general population. By contrast, the risk could be lower in the Klinefelter variants with more than 3 supplementary X chromosomes, owing to an earlier and more profound destruction of Leydig cells rendering them irresponsive to chronic Luteinizing hormone (LH) stimulation.

【 授权许可】

   
2015 Maqdasy et al.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Tartaglia N, Ayari N, Howell S, D’Epagnier C, Zeitler P. 48,XXYY, 48,XXXY and 49,XXXXY syndromes: not just variants of Klinefelter syndrome. Acta Paediatr Oslo Nor 1992. 2011; 100:851-860.
• [2]Linden MG, Bender BG, Robinson A. Sex chromosome tetrasomy and pentasomy. Pediatrics. 1995; 96(4 Pt 1):672-682.
• [3]Klinefelter HF, Reifenstein EC, Albright F. Syndrome characterized by gynecomastia, aspermatogenesis without A-Leydigism, and increased excretion of follicle-stimulating hormone1. J Clin Endocrinol Metab. 1942; 2:615-627.
• [4]Fromantin M, Pesquies P, Serrurier B, Gautier D, Canivet B, Grenier J, Scholler R. Klinefelter’s syndrome in 19 year old adolescents. (100 cases detected during selection for National Service). Ann Méd Interne. 1977; 128:239-244.
• [5]Visootsak J, Ayari N, Howell S, Lazarus J, Tartaglia N. Timing of diagnosis of 47, XXY and 48, XXYY: A survey of parent experiences. Am J Med Genet A. 2013; 161:268-272.
• [6]Van Assche E, Bonduelle M, Tournaye H, Joris H, Verheyen G, Devroey P, Van Steirteghem A, Liebaers I. Cytogenetics of infertile men. Hum Reprod Oxf Engl. 1996; 11 Suppl 4:1-24.
• [7]Groth KA, Skakkebæk A, Høst C, Gravholt CH, Bojesen A. Klinefelter syndrome—a clinical update. J Clin Endocrinol Metab. 2013; 98:20-30.
• [8]Swerdlow AJ, Higgins CD, Schoemaker MJ, Wright AF, Jacobs PA. Mortality in patients with Klinefelter syndrome in Britain: a cohort study. J Clin Endocrinol Metab. 2005; 90:6516-6522.
• [9]Hasle H, Mellemgaard A, Nielsen J, Hansen J. Cancer incidence in men with Klinefelter syndrome. Br J Cancer. 1995; 71:416-420.
• [10]Peet J, Weaver DD, Vance GH. 49, XXXXY: a distinct phenotype. Three new cases and review. J Med Genet. 1998; 35:420-424.
• [11]Robinson A, Bender BG, Linden MG, Salbenblatt JA. Sex chromosome aneuploidy: the Denver prospective study. Birth Defects Orig Artic Ser. 1990; 26:59-115.
• [12]Sprouse C, Tosi L, Stapleton E, Gropman AL, Mitchell FL, Peret R, Sadeghin T, Haskell K, Samango-Sprouse CA. Musculoskeletal anomalies in a large cohort of boys with 49, XXXXY. Am J Med Genet C Semin Med Genet. 2013; 163C:44-49.
• [13]Ottesen AM, Aksglaede L, Garn I, Tartaglia N, Tassone F, Gravholt CH, Bojesen A, Sørensen K, Jørgensen N, Rajpert-De Meyts E, Gerdes T, Lind A-M, Kjaergaard S, Juul A. Increased number of sex chromosomes affects height in a nonlinear fashion: a study of 305 patients with sex chromosome aneuploidy. Am J Med Genet A. 2010; 152A:1206-1212.
• [14]Tartaglia N, Davis S, Hench A, Nimishakavi S, Beauregard R, Reynolds A, Fenton L, Albrecht L, Ross J, Visootsak J, Hansen R, Hagerman R. A new look at XXYY syndrome: medical and psychological features. Am J Med Genet A. 2008; 146A:1509-1522.
• [15]Blumenthal JD, Baker EH, Lee NR, Wade B, Clasen LS, Lenroot RK, Giedd JN. Brain morphological abnormalities in 49, XXXXY syndrome: A pediatric magnetic resonance imaging study. NeuroImage Clin. 2013; 2:197-203.
• [16]Giedd JN, Clasen LS, Wallace GL, Lenroot RK, Lerch JP, Wells EM, Blumenthal JD, Nelson JE, Tossell JW, Stayer C, Evans AC, Samango-Sprouse CA. XXY (Klinefelter Syndrome): a pediatric quantitative brain magnetic resonance imaging case–control study. Pediatrics. 2007; 119:e232-e240.
• [17]Gropman AL, Rogol A, Fennoy I, Sadeghin T, Sinn S, Jameson R, Mitchell F, Clabaugh J, Lutz-Armstrong M, Samango-Sprouse CA. Clinical variability and novel neurodevelopmental findings in 49, XXXXY syndrome. Am J Med Genet A. 2010; 152A:1523-1530.
• [18]Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto A-M, Schmidt IM, Chellakooty M, Damgaard IN, Mau C, Reunanen M, Skakkebaek NE, Toppari J. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet. 2004; 363:1264-1269.
• [19]Foresta C, Zuccarello D, Garolla A, Ferlin A. Role of hormones, genes, and environment in human cryptorchidism. Endocr Rev. 2008; 29:560-580.
• [20]Christiansen P, Andersson A-M, Skakkebæk NE. Longitudinal studies of inhibin B levels in boys and young adults with Klinefelter syndrome. J Clin Endocrinol Metab. 2003; 88:888-891.
• [21]Salbenblatt JA, Bender BG, Puck MH, Robinson A, Faiman C, Winter JS. Pituitary-gonadal function in Klinefelter syndrome before and during puberty. Pediatr Res. 1985; 19:82-86.
• [22]Ross JL, Samango-Sprouse C, Lahlou N, Kowal K, Elder FF, Zinn A. Early androgen deficiency in infants and young boys with 47, XXY Klinefelter syndrome. Horm Res. 2005; 64:39-45.
• [23]Cabrol S, Ross JL, Fennoy I, Bouvattier C, Roger M, Lahlou N. Assessment of Leydig and Sertoli cell functions in infants with nonmosaic Klinefelter syndrome: insulin-like peptide 3 levels are normal and positively correlated with LH levels. J Clin Endocrinol Metab. 2011; 96:E746-753.
• [24]Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer J Int Cancer. 2005; 115:822-827.
• [25]Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA. International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomark Prev. 2010; 19:1151-1159.
• [26]Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127:2893-2917.
• [27]Hekimgil M, Altay B, Yakut BD, Soydan S, Ozyurt C, Killi R. Leydig cell tumor of the testis: comparison of histopathological and immunohistochemical features of three azoospermic cases and one malignant case. Pathol Int. 2001; 51:792-796.
• [28]Henderson CG, Ahmed AA, Sesterhenn I, Belman AB, Rushton HG. Enucleation for prepubertal leydig cell tumor. J Urol. 2006; 176:703-705.
• [29]Agarwal PK, Palmer JS. Testicular and paratesticular neoplasms in prepubertal males. J Urol. 2006; 176:875-881.
• [30]Farkas LM, Székely JG, Pusztai C, Baki M. High frequency of metastatic Leydig cell testicular tumours. Oncology 2000, 59:118–121
• [31]Skakkebaek NE, Holm M, Hoei-Hansen C, Jørgensen N, Rajpert-De Meyts E. Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. APMIS Acta Pathol Microbiol Immunol Scand. 2003; 111:1-9.
• [32]Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol. 2003; 200:370-374.
• [33]Giwercman A, Grindsted J, Hansen B, Jensen OM, Skakkebaek NE. Testicular cancer risk in boys with maldescended testis: a cohort study. J Urol. 1987; 138:1214-1216.
• [34]Giwercman A, Bruun E, Frimodt-Møller C, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol. 1989; 142:998-1001.
• [35]Prener A, Engholm G, Jensen OM. Genital anomalies and risk for testicular cancer in Danish men. Epidemiol Camb Mass. 1996; 7:14-19.
• [36]Møller H, Skakkebaek NE. Risk of testicular cancer in subfertile men: case–control study. BMJ. 1999; 318:559-562.
• [37]Paduch DA. Testicular cancer and male infertility. Curr Opin Urol. 2006; 16:419-427.
• [38]Jacobsen R, Bostofte E, Engholm G, Hansen J, Skakkebaek NE, Møller H. Fertility and offspring sex ratio of men who develop testicular cancer: a record linkage study. Hum Reprod Oxf Engl. 2000; 15:1958-1961.
• [39]Ferguson L, Agoulnik AI: Testicular Cancer and Cryptorchidism. Front Endocrinol(Lausanne) 2013;432. doi: 10.3389/fendo.2013.00032. eCollection 2013.10.3389/fendo.2013.00032
• [40]Singh R, Shastry PK, Rasalkar AA, Singh L, Thangaraj K. A novel androgen receptor mutation resulting in complete androgen insensitivity syndrome and bilateral Leydig cell hyperplasia. J Androl. 2006; 27:510-516.
• [41]Swerdlow AJ, Schoemaker MJ, Higgins CD, Wright AF, Jacobs PA. Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst. 2005; 97:1204-1210.
• [42]Bojesen A, Juul S, Birkebaek N, Gravholt CH. Increased mortality in Klinefelter syndrome. J Clin Endocrinol Metab. 2004; 89:3830-3834.
• [43]Hasle H, Jacobsen BB, Asschenfeldt P, Andersen K. Mediastinal germ cell tumour associated with Klinefelter syndrome. A report of case and review of the literature. Eur J Pediatr. 1992; 151:735-739.
• [44]Chetaille B, Massard G, Falcoz P-E. Les tumeurs germinales du médiastin : anatomopathologie, classification, tératomes et tumeurs malignes. Rev Pneumol Clin. 2010; 66:63-70.
• [45]Ahmad KN, Dykes JRW, Ferguson-Smith MA, Lennox B, Mack WS. Leydig cell volume in chromatin-positive Klinefelter’s syndrome. J Clin Endocrinol Metab. 1971; 33:517-520.
• [46]Accardo G, Vallone G, Esposito D, Barbato F, Renzullo A, Conzo G, Docimo G, Esposito K, Pasquali D. Testicular parenchymal abnormalities in Klinefelter syndrome: a question of cancer? Examination of 40 consecutive patients. Asian J Androl. 2015; 17:154-158.
• [47]Carmignani L, Bozzini G. Re: Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis: J. D. Raman, C. F. Nobert and M. Goldstein. J Urol. 2006; 175:1574.
• [48]Butruille C, Marcelli F, Ghoneim T, Lemaitre L, Puech P, Leroy X, Rigot J-M. Prise en charge des nodules testiculaires dans une population de patients infertiles. Prog En Uro. 2012; 22:45-52.
• [49]Bojesen A, Juul S, Gravholt CH. Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab. 2003; 88:622-626.
• [50]Bojesen A, Juul S, Birkebæk NH, Gravholt CH. Morbidity in Klinefelter syndrome: A Danish register study based on hospital discharge diagnoses. J Clin Endocrinol Metab. 2006; 91:1254-1260.
• [51]Hutson JM, Balic A, Nation T, Southwell B. Cryptorchidism. Semin Pediatr Surg. 2010; 19:215-224.
• [52]Hutson JM. Undescended testis: the underlying mechanisms and the effects on germ cells that cause infertility and cancer. J Pediatr Surg. 2013; 48:903-908.
• [53]Christensen AK, Peacock KC. Increase in Leydig cell number in testes of adult rats treated chronically with an excess of human chorionic gonadotropin. Biol Reprod. 1980; 22:383-391.
• [54]Prahalada S, Majka JA, Soper KA, Nett TM, Bagdon WJ, Peter CP, Burek JD, MacDonald JS, van Zwieten MJ. Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5 alpha-reductase inhibitor: a possible mechanism. Fundam Appl Toxicol Off J Soc Toxicol. 1994; 22:211-219.
• [55]Shenker A, Laue L, Kosugi S, Merendino JJ, Minegishi T, Cutler GB. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 1993; 365:652-654.
• [56]Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med. 1999; 341:1731-1736.
• [57]Olivier P, Simoneau-Roy J, Francoeur D, Sartelet H, Parma J, Vassart G, Van Vliet G. Leydig cell tumors in children: contrasting clinical, hormonal, anatomical, and molecular characteristics in boys and girls. J Pediatr. 2012; 161:1147-1152.
• [58]Goji K, Teraoka Y, Hosokawa Y, Okuno M, Ozaki K, Yoshida M, Matsuo M. Gonadotropin-independent precocious puberty associated with a somatic activating mutation of the LH receptor gene: detection of a mutation present in only a small fraction of cells from testicular tissue using wild-type blocking polymerase chain reaction and laser-capture microdissection. Endocrine. 2009; 35:397-401.
• [59]Boot AM, Lumbroso S, Verhoef-Post M, Richter-Unruh A, Looijenga LHJ, Funaro A, Beishuizen A, van Marle A, Drop SLS, Themmen APN. Mutation analysis of the LH receptor gene in Leydig cell adenoma and hyperplasia and functional and biochemical studies of activating mutations of the LH receptor gene. J Clin Endocrinol Metab. 2011; 96:E1197-1205.
• [60]Sangkhathat S, Kanngurn S, Jaruratanasirikul S, Tubtawee T, Chaiyapan W, Patrapinyokul S, Chiengkriwate P. Peripheral precocious puberty in a male caused by Leydig cell adenoma harboring a somatic mutation of the LHR gene: report of a case. J Med Assoc Thai Chotmaihet Thangphaet. 2010; 93:1093-1097.
• [61]D’ Alva CB, Brito VN, Palhares HMC, Carvalho FM, Arnhold IJP, Mendonca BB, Latronico AC. A single somatic activating Asp578His mutation of the luteinizing hormone receptor causes Leydig cell tumour in boys with gonadotropin-independent precocious puberty. Clin Endocrinol (Oxf). 2006; 65:408-410.
• [62]Canto P, Söderlund D, Ramón G, Nishimura E, Méndez JP. Mutational analysis of the luteinizing hormone receptor gene in two individuals with Leydig cell tumors. Am J Med Genet. 2002; 108:148-152.
• [63]Richter-Unruh A, Wessels HT, Menken U, Bergmann M, Schmittmann-Ohters K, Schaper J, Tappeser S, Hauffa BP. Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. J Clin Endocrinol Metab. 2002; 87:1052-1056.
• [64]Kiepe D, Richter-Unruh A, Autschbach F, Kessler M, Schenk JP, Bettendorf M. Sexual pseudo-precocity caused by a somatic activating mutation of the LH receptor preceding true sexual precocity. Horm Res. 2008; 70:249-253.
• [65]Kremer H, Martens JW, van Reen M, Verhoef-Post M, Wit JM, Otten BJ, Drop SL, Delemarre-van de Waal HA, Pombo-Arias M, De Luca F, Potau N, Buckler JM, Jansen M, Parks JS, Latif HA, Moll GW, Epping W, Saggese G, Mariman EC, Themmen AP, Brunner HG. A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. J Clin Endocrinol Metab. 1999; 84:1136-1140.
• [66]Eicher EM, Hale DW, Hunt PA, Lee BK, Tucker PK, King TR, Eppig JT, Washburn LL. The mouse Y* chromosome involves a complex rearrangement, including interstitial positioning of the pseudoautosomal region. Cytogenet Cell Genet. 1991; 57:221-230.
• [67]Wistuba J, Luetjens CM, Stukenborg J-B, Poplinski A, Werler S, Dittmann M, Damm OS, Hämäläinen T, Simoni M, Gromoll J. Male 41, XXY* mice as a model for klinefelter syndrome: hyperactivation of leydig cells. Endocrinology. 2010; 151:2898-2910.
• [68]Wistuba J. Animal models for Klinefelter’s syndrome and their relevance for the clinic. Mol Hum Reprod. 2010; 16:375-385.
• [69]Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A. 1992; 89:5152-5156.
• [70]Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991; 325:1688-1695.
• [71]Fragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, Araujo LM, Lando VS, Frazzatto ET, Mendonca BB, Villares SM. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocrinol Metab. 1998; 83:2074-2078.
• [72]Boyce AM, Chong WH, Shawker TH, Pinto PA, Linehan WM, Bhattacharryya N, Merino MJ, Singer FR, Collins MT. Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab. 2012; 97:E1782-1790.
• [73]Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore). 1985; 64:270-283.
• [74]Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 2001; 86:4041-4046.
• [75]Tazi MF, Ahallal Y, Khallouk A, Elfatemi H, Bendahou M, Tazi E, El Fassi MJ, Farih MH. Concomitant sertoli and leydig cell tumor of the testis: a case report. Rev Urol. 2011; 13:173-175.
• [76]Carmignani L, Gadda F, Mancini M, Gazzano G, Nerva F, Rocco F, Colpi GM. Detection of testicular ultrasonographic lesions in severe male infertility. J Urol. 2004; 172:1045-1047.
• [77]Maizlin ZV, Belenky A, Kunichezky M, Sandbank J, Strauss S. Leydig cell tumors of the testis: gray scale and color Doppler sonographic appearance. J Ultrasound Med. 2004; 23:959-964.
• [78]Loeser A, Vergho DC, Katzenberger T, Brix D, Kocot A, Spahn M, Gerharz EW, Riedmiller H. Testis-sparing surgery versus radical orchiectomy in patients with Leydig cell tumors. Urology. 2009; 74:370-372.
• [79]Carmignani L, Colombo R, Gadda F, Galasso G, Lania A, Palou J, Algaba F, Villavicencio H, Colpi GM, Decobelli O, Salvioni R, Pizzocaro G, Rigatti P, Rocco F. Conservative surgical therapy for leydig cell tumor. J Urol. 2007; 178:507-511.
• [80]Nicolai N, Necchi A, Raggi D, Biasoni D, Catanzaro M, Piva L, Stagni S, Maffezzini M, Torelli T, Faré E, Giannatempo P, Pizzocaro G, Colecchia M, Salvioni R. Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease. Urology. 2015; 85:402-406.
• [81]Giannarini G, Mogorovich A, Menchini Fabris F, Morelli G, De Maria M, Manassero F, Loggini B, Pingitore R, Cavazzana A, Selli C. Long-term followup after elective testis sparing surgery for Leydig cell tumors: a single center experience. J Urol. 2007; 178(3 Pt 1):872-876.
• [82]Bozzini G, Picozzi S, Gadda F, Colombo R, Decobelli O, Palou J, Colpi G, Carmignani L. Long-term follow-up using testicle-sparing surgery for leydig cell tumor. Clin Genitourin Cancer. 2013; 11(3):321-4.
• [83]Masoudi JF, Van Arsdalen K, Rovner ES. Organ-sparing surgery for bilateral leydig cell tumor of the testis. Urology. 1999; 54:744.
• [84]Giannarini G, Dieckmann K-P, Albers P, Heidenreich A, Pizzocaro G. Organ-sparing surgery for adult testicular tumours: a systematic review of the literature. Eur Urol. 2010; 57:780-790.
• [85]Steiner H, Höltl L, Maneschg C, Berger AP, Rogatsch H, Bartsch G, Hobisch A. Frozen section analysis-guided organ-sparing approach in testicular tumors: technique, feasibility, and long-term results. Urology. 2003; 62:508-513.
• [86]Grem JL, Robins HI, Wilson KS, Gilchrist K, Trump DL. Metastatic Leydig cell tumor of the testis. Report of three cases and review of the literature. Cancer. 1986; 58:2116-2119.
• [87]Bertram KA, Bratloff B, Hodges GF, Davidson H. Treatment of malignant Leydig cell tumor. Cancer. 1991; 68:2324-2329.
• [88]Bokemeyer C, Harstrick A, Gonnermann O, Schober C, Kuczyk M, Poliwoda H, Schmoll H. Metastatic Leydig-cell tumors of the testis - report of 4 cases and review of the literature. Int J Oncol. 1993; 2:241-244.
• [89]Yoshida T, Takao T, Tsujimura A, Tomita H, Aozasa K, Okuyama A. Testicular epidermoid cyst in Klinefelter’s syndrome. Int J Urol Off J Jpn Urol Assoc. 2006; 13:478-480.
• [90]Carroll PR, Morse MJ, Koduru PP, Chaganti RS. Testicular germ cell tumor in patient with Klinefelter syndrome. Urology. 1988; 31:72-74.
• [91]Sasagawa I, Nakada T, Kazama T, Sakamoto M, Satomi S, Katayama T. Epidermoid cyst of the testis in Klinefelter’s syndrome. Urol Int. 1987; 42:398-400.
• [92]Baniel J, Perez JM, Foster RS. Benign testicular tumor associated with Klinefelter’s syndrome. J Urol. 1994; 151:157-158.
• [93]Reddy SR, Svec F, Richardson P. Seminoma of the testis in a patient with 48, XXYY variant of Klinefelter’s syndrome. South Med J. 1991; 84:773-775.
• [94]Isurugi K, Imao S, Hirose K, Aoki H. Seminoma in Klinefelter’s syndrome with 47, XXY, 15 s + karyotype. Cancer. 1977; 39:2041-2047.
• [95]Tada M, Takimoto Y, Kishimoto T. Immature teratoma of the testis associated with Klinefelter’s syndrome: a case report. Hinyokika Kiyo. 1990; 36:1471-1474.
• [96]Stevens MJ, Jameson CF, Hendry WF. Bilateral testicular teratoma in Klinefelter’s syndrome. Br J Urol. 1993; 72:384-385.
• [97]Matsuki S, Sasagawa I, Kakizaki H, Suzuki Y, Nakada T. Testicular teratoma in a man with XX/XXY mosaic Klinefelter’s syndrome. J Urol. 1999; 161:1573-1574.
• [98]Simpson JL, Photopulos G. Letter: Bilateral teratoma of testis in 2 brothers with 47, XXY Klinefelter’s syndrome. Clin Genet. 1976; 9:380-381.
• [99]Gustavson KH, Gamstorp I, Meurling S. Bilateral teratoma of testis in two brothers with 47, XXY Klinefelter’s syndrome. Clin Genet. 1975; 8:5-10.
• [100]Ekerhovd E, Westlander G. Testicular sonography in men with Klinefelter syndrome shows irregular echogenicity and blood flow of high resistance. J Assist Reprod Genet. 2002; 19:517-522.
• [101]Lardennois B, El Hansa A, Bernier F, Birembaut P, Caron J, Lemaire P. Klinefelter’s disease and leydigiomas. A report of one case (author’s transl). J Urol (Paris). 1981; 87:631-634.
• [102]Soria JC, Durdux C, Chrétien Y, Sibony M, Damotte D, Housset M. Malignant Leydig cell tumor of the testis associated with Klinefelter’s syndrome. Anticancer Res. 1999; 19:4491-4494.
• [103]ARDUINO LJ, GLUCKSMAN MA. Interstitial cell tumor of the testis associated with Klinefelter’s syndrome: a case report. J Urol. 1963; 89:246-248.
• [104]Dodge OG, Jackson AW, Muldal S. Breast cancer and interstitial-cell tumor in a patient with Klinefelter’s syndrome. Cancer. 1969; 24:1027-1032.
• [105]Knyrim K, Higi M, Hossfeld DK, Seeber S, Schmidt CG. Autonomous cortisol secretion by a metastatic Leydig cell carcinoma associated with Klinefelter’s syndrome. J Cancer Res Clin Oncol. 1981; 100:85-93.
• [106]Poster RB, Katz DS. Leydig cell tumor of the testis in Klinefelter syndrome: MR detection. J Comput Assist Tomogr. 1993; 17:480-481.
• [107]Okada H, Gotoh A, Takechi Y, Kamidono S. Leydig cell tumour of the testis associated with Klinefelter’s syndrome and Osgood-Schlatter disease. Br J Urol. 1994; 73:457.
• [108]Westlander G, Ekerhovd E, Granberg S, Hanson L, Hanson C, Bergh C. Testicular ultrasonography and extended chromosome analysis in men with nonmosaic Klinefelter syndrome: a prospective study of possible predictive factors for successful sperm recovery. Fertil Steril. 2001; 75:1102-1105.
• [109]Heer R, Jackson MJ, El-Sherif A, Thomas DJ. Twenty-nine Leydig cell tumors: histological features, outcomes and implications for management. Int J Urol Off J Jpn Urol Assoc. 2010; 17:886-889.
• [110]Fishman MDC, Eisenberg DA, Horrow MM. Klinefelter syndrome with leydig cell tumor/hyperplasia. Ultrasound Q. 2010; 26:101-102.
• [111]De Miguel MP, Regadera J, Martinez-Garcia F, Nistal M, Paniagua R. Oncostatin M in the normal human testis and several testicular disorders. J Clin Endocrinol Metab. 1999; 84:768-774.